Showing results (1461-1470 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|December 15, 2022
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemiaHeikki Kuusanmäki, Sari Kytölä, Ida Vänttinen, et al.
Haematologica|December 15, 2022
A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantationMichelle Hudspeth, Shahram Mori, David Nachbaur, et al.
Haematologica|December 7, 2022
Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiencyAvigail Rein, Ifat Geron, Eitan Kugler, et al.
Haematologica|December 7, 2022
Adipocytes control hematopoiesis and inflammation through CD40 signalingMyrthe E Reiche, Kikkie Poels, Laura A Bosmans, et al.
Haematologica|November 24, 2022
Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemiaDino Masic, Kayleigh Fee, Hayden Bell, et al.
Haematologica|November 24, 2022
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphomaLingzhi Li, Lei Nie, Alexa Jordan, et al.
Haematologica|June 30, 2022
IgM monoclonal gammopathies of clinical significance: diagnosis and managementJahanzaib Khwaja, Shirley D'Sa, Monique C Minnema, et al.
Haematologica|April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life studySophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Haematologica|December 10, 2020
Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potentialLennart Raman, Malaïka Van der Linden, Ciel De Vriendt, et al.
Haematologica|December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Pageof 815